Topic: How To Invest

I would appreciate your comments regarding the following U.S. stock: Becton Dickinson. Thank you.

Article Excerpt

Becton, Dickinson & Co., $78.35, symbol BDX on New York (Shares outstanding: 223.6 million; Market cap: $17.5 billion; www.bd.com), has three main businesses. The medical division (which supplies 51% of the company’s sales) makes a wide range of medical devices, including needles, syringes and intravenous catheters; the diagnostics division (32% of sales) sells products for the safe collection and transport of diagnostic specimens, as well as products used to detect infectious diseases, cancers and health-care-associated infections; the biosciences division (17%) makes tools for studying of cells. In March 2011, the company bought Accuri Cytometers, Inc. This company specializes in flow cytometers, which help medical researchers separate microscopic particles, such as cells and chromosomes. This helps speed up the diagnosis of health disorders. Becton paid $205.0 million for Accuri. To put that in context, Becton earned $338.1 million in the three months ended June 30, 2011. That’s up 14.9% from $294.2 million a year earlier. Earnings per share rose 22.8%, to $1.51…